Bruce & Co., Inc. Lava Therapeutics Nv Transaction History
Bruce & Co., Inc.
- $240 Million
- Q3 2024
A detailed history of Bruce & Co., Inc. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Bruce & Co., Inc. holds 771,874 shares of LVTX stock, worth $802,748. This represents 0.53% of its overall portfolio holdings.
Number of Shares
771,874
Previous 771,874
-0.0%
Holding current value
$802,748
Previous $1.39 Million
7.78%
% of portfolio
0.53%
Previous 0.68%
Shares
3 transactions
Others Institutions Holding LVTX
# of Institutions
28Shares Held
3.61MCall Options Held
32.9KPut Options Held
500-
Redmile Group, LLC San Francisco, CA2.07MShares$2.16 Million0.23% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3146KShares$152,3150.04% of portfolio
-
Two Sigma Investments, LP New York, NY103KShares$106,8760.0% of portfolio
-
Pathway Financial Advisors LLC103KShares$106,6000.04% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$90,8920.07% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $26.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...